Grivas, P., Warner, J., Shyr, Y., Shah, D., Rubinstein, S. M., Kuderer, N. M., … Lopes, G. (2020). LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19). In Annals of Oncology (Vol. 31, pp. S1202–S1203). Elsevier BV. https://doi.org/10.1016/j.annonc.2020.08.2313

Grivas, P., J. Warner, Y. Shyr, D. Shah, S. M. Rubinstein, N. M. Kuderer, T. K. Choueiri, et al. “LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19).” In Annals of Oncology, 31:S1202–3. Elsevier BV, 2020. https://doi.org/10.1016/j.annonc.2020.08.2313.

Grivas P, Warner J, Shyr Y, Shah D, Rubinstein SM, Kuderer NM, et al. LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19). In: Annals of Oncology. Elsevier BV; 2020. p. S1202–3.

Grivas, P., et al. “LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19).” Annals of Oncology, vol. 31, Elsevier BV, 2020, pp. S1202–03. Crossref, doi:10.1016/j.annonc.2020.08.2313.

Grivas P, Warner J, Shyr Y, Shah D, Rubinstein SM, Kuderer NM, Choueiri TK, Rivera D, Painter C, Thompson MA, Peters S, Desai A, Khaki AR, Pennell NA, Hawley J, Halmos B, Puc MM, Lyman GH, Rini BI, Lopes G. LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19). Annals of Oncology. Elsevier BV; 2020. p. S1202–S1203.